Estrogen receptors alpha and beta and the risk of open-angle glaucoma: the Rotterdam Study

Arch Ophthalmol. 2008 Jan;126(1):110-4. doi: 10.1001/archopht.126.1.110.

Abstract

Objective: To investigate whether polymorphisms in the estrogen receptor alpha (ESR1) and beta (ESR2) genes were a risk factor for open-angle glaucoma (OAG).

Methods: Participants 55 years and older from the population-based Rotterdam Study underwent, at baseline and at follow-up, the same ophthalmic examination, including visual field screening and stereo optic disc photography. A diagnosis of OAG was based on an algorithm using optic disc measures and visual field loss. Haplotypes of the ESR1 and ESR2 genes were determined.

Results: We diagnosed incident OAG in 87 of 3842 participants (2.3%) at risk after a mean follow-up of 6.5 years. We could not detect any association with ESR1 haplotypes. Haplotype 1 of ESR2 showed a 3.6-fold (95% confidence interval, 1.4-9.2) higher risk of incident OAG in men. In women, no association was found between ESR2 and incident OAG.

Conclusion: Polymorphisms in the ESR1 gene are unrelated to OAG, but ESR2 polymorphisms seem to lead to increased risk of OAG in men.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Algorithms
  • Estrogen Receptor alpha / genetics*
  • Estrogen Receptor beta / genetics*
  • Female
  • Glaucoma, Open-Angle / diagnosis
  • Glaucoma, Open-Angle / epidemiology
  • Glaucoma, Open-Angle / genetics*
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Optic Disk / pathology
  • Polymorphism, Single Nucleotide*
  • Risk Factors
  • Sex Factors
  • Vision Disorders / diagnosis
  • Visual Fields

Substances

  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Estrogen Receptor beta